Trending...
- Making Time for Mythic Adventure - 175
- Long Beach: City Recaps Preparedness and Response Efforts on Peninsula Following Hurricane Marie Impacts - 119
- 'Nightmare' Star Mckenna Bridger Talks Psychological Thriller, Two-Part Shoot And Taking On Violet Adams - 113
SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11th. Presentations will be available for registered attendees via the conference website.
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
- GridSignal Launches Free Diagnostic to Reveal Hidden Power Capacity in AI Data Centers
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- California: Trump wants to send a check? Pay Americans back the $108 billion his Iran War cost them at the pump first
- Reboot Ridge Introduces a Different Kind of Men's Wellness Retreat in San Diego, CA
- Dolly Parton And Loretta Lynn Tribute "At Heaven's Country Gate" Passes 55,000 YouTube Views
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
Filed Under: Business
0 Comments
Latest on The Californer
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Attn: Art Editors, Computer Programmers and of course, AI: Here is a painting about life in our computerized world. It's a painting called CLICK HERE
- California: Governor Newsom signs new law to protect workers, require disclosures on AI-generated advertising
- Pervaziv AI Unveils Cortex Discover, an Agentic AI Browser Built for Governed Enterprise Work
- LovelySkin launches The Nine Aurora following the discovery of nine Skin Longevity Zones
- Governor Newsom visits Jay Leno's Garage to sign legislation celebrating and preserving California's classic car and lowrider heritage
- Mesa West Capital Originates $27 Million Loan for Seattle Apartment Acquisition
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- SkillFront Launches ISO 9001:2026 Enterprise Certification on September 16, 2026
- Learn Window Tinting in Los Angeles: Tint Academy LA Window Tint Trainin
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Most Indiana Plane Crashes Happen Away from the State's Major Airports
- L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
- SMG Opens 2027 IMPACT Awards With Customer Experience, Employee Experience, Enterprise AI Categories
- System4 San Francisco East Bay Completes Three-Kitchen Deep Cleaning Project in Pleasanton
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
- California: Governor Newsom proclaims Latino Heritage Month
- Long Beach Public Works to Host Community Meeting on Anaheim Street Corridor Improvement Project
- Attn: ALL BUSINESSES: Read this book about this Marketing Math and start using this math TODAY!